A new recommendation
PBAC recommends listing of adalimumab biosimilar The PBAC has recommended the Authority Required listing of adalimumab (Yuflyma) in the form of 40 mg in 0.4 mL pre-filled syringe and pre-filled …
Pandemic spending ‘spike’ at discount pharmacies
Spending on retail and other health services swelled by almost 60% across Australian community pharmacies over the past three years, new report reveals Pharmacy spending increased by 21%–or $20 million—across …
“We put little handmade love hearts into everyone’s deliveries saying, ‘you’re not alone’.”
Ruth Parker has been voted Most Outstanding Community Pharmacist by her Beechworth community after shepherding them through the pandemic Ruth Parker, the sole proprietor of the only pharmacy in Victoria’s …
A question of risk
Interim decision knocks back cannabis downschedule proposal for research purposes, citing “risks of misuse, abuse and diversion” A delegate to the TGA has knocked back a recent proposal to introduce …
Downschedule decision on allergic rhinitis drugs
Bid to downschedule existing fixed-dose combination products containing both azelastine and fluticasone propionate rejected in interim decision An application to amend the existing S2 entries for azelastine and fluticasone propionate …
Medication errors: learning from coroners’ cases
How can pharmacists learn from incidents such as the deaths of a 19-year-old who received a 10-fold dose of haloperidol, or an opiate-naïve woman from fentanyl overdose? Reviewing the circumstances …
Local access to mRNA vaccines locked in
A new vaccine manufacturing facility will be built at Monash University as government strikes new deal An mRNA vaccine manufacturing facility will be built at Melbourne’s Monash University after the …
‘There’s a fair degree of trial and error at the moment.’
Chronic non-cancer pain is the leading indication for special access to medicinal cannabis products, despite doctors being urged not to prescribe for this indication Medicinal cannabis applications for chronic pain …
RACGP labels Pharmacy Guild’s claims ‘unfounded and misleading’
Doctors’ group rejects allegations that GP patient wait times are endangering those with COVID-19 The RACGP has rejected the Pharmacy Guild’s assertion that GP wait times are leading to delays …
Fines over COVID-19 masks, RATs
The Federal court has ordered one company to pay $80k over face mask breach, while another has been fined $67k for failing to provide information on its RATs The TGA …
A new role
Professor Faye McMillan AM to join UTS faculty Pharmacist Faye McMillan will be joining the UTS Faculty of Health as Professor of Indigenous Health within the School of Public Health …
Changes for ‘better work-life balance’
Another pharmacy chain is set to change its opening hours to support better health and wellbeing for its pharmacy teams Morrisons in the UK has announced it will be introducing …